scholarly journals Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

2019 ◽  
Vol 7 (10) ◽  
pp. 1957-1961
Author(s):  
Jessica D. Rich ◽  
Stephen M. Clark ◽  
Yuri Fedoriw ◽  
Valerie Jewells ◽  
William Wood ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Stem Cell ◽  
Case Report ◽  
Stem Cell Transplant ◽  
Cell Lymphoma ◽  
Central Nervous System Relapse ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Mantle Cell

scholarly journals T-Cell Replete Allogeneic Stem Cell Transplant Is an Effective Treatment Option for Patients with TP53 mutated Mantle Cell Lymphoma

2021 ◽  
Vol 27 (3) ◽  
pp. S421-S422
Author(s):  
Edward Robert Scheffer Cliff ◽  
Thomas Eliot Lew ◽  
Piers Blombery ◽  
Michael Dickinson ◽  
Constantine S. Tam ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Mantle Cell Lymphoma ◽  
Effective Treatment ◽  
Stem Cell Transplant ◽  
Cell Lymphoma ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Effective Treatment Option ◽  
Mantle Cell

Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma

2014 ◽  
Vol 55 (8) ◽  
pp. 1935-1938 ◽  
Author(s):  
Andrea Janikova ◽  
Andrea Mareckova ◽  
Aneta Baumeisterova ◽  
Marta Krejci ◽  
Jana Supikova ◽  
...  
Keyword(s):  
Stem Cell ◽  
Mantle Cell Lymphoma ◽  
Stem Cell Transplant ◽  
Cell Lymphoma ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Mantle Cell

scholarly journals Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Rui Bergantim ◽  
Juliana Bastos ◽  
Maria José Soares ◽  
Bruno Carvalho ◽  
Pedro Soares ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Multiple Myeloma ◽  
Nervous System ◽  
Stem Cell ◽  
Stem Cell Transplant ◽  
Systemic Disease ◽  
Autologous Stem Cell Transplant ◽  
Central Nervous System Relapse ◽  
Cell Transplant ◽  
Extramedullary Disease

Extramedullary disease is an aggressive presentation at diagnosis and relapse for multiple myeloma (MM) patients. Central nervous system (CNS) is a very rare manifestation of the extramedullary disease, accounting for less than 1% of MM on diagnosis and relapse. Neurological symptoms are unspecific and usually attributed to other causes. We present two patients with CNS-MM at relapse after autologous stem cell transplant highlighting the importance of clinical suspicion and interdisciplinarity at diagnostic workup as well as the need for intensive therapeutic options on such rare and aggressive cases. The presence of neurological abnormalities in anamnesis and physical examination on a patient with MM should always prompt to suspect of a CNS involvement, and active investigation must be undertaken. MRI is the standard radiological method to detect CNS-MM, with histopathological corroboration by stereotactic biopsy and CSF evaluation alongside. Treatment of CNS-MM should include two essential approaches—be able to cross the BBB and treat the systemic disease. There is no standard therapy for this extramedullary relapse, and a tailored and multiple therapy should be promptly started—intrathecal therapy, radiotherapy, and systemic therapy, including an immunomodulator.

scholarly journals Central nervous system aspergillosis in allogeneic stem cell transplant recipients

2003 ◽  
Vol 31 (3) ◽  
pp. 191-196 ◽  
Author(s):  
E Jantunen ◽  
L Volin ◽  
O Salonen ◽  
A Piilonen ◽  
T Parkkali ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Stem Cell ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document